| 86R98 LED-D  
---|---  
|  By: King of Hemphill | H.B. No. 670  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to health benefit plan coverage for ovarian cancer testing  
| and screening.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Section 1370.003(b), Insurance Code, is amended  
| to read as follows:  
|  (b) Coverage required under this section includes at a  
| minimum:  
|  (1) a CA 125 blood test; [ ~~and~~ ]  
|  (2) a conventional Pap smear screening or a screening  
| using liquid-based cytology methods, as approved by the United  
| States Food and Drug Administration, alone or in combination with a  
| test approved by the United States Food and Drug Administration for  
| the detection of the human papillomavirus _; and_  
|  _(3)_ _____any other test or screening approved by the United_  
| _States Food and Drug Administration for the detection of ovarian_  
| _cancer_.  
|  SECTION 2. Section 1370.003, Insurance Code, as amended by  
| this Act, applies only to a health benefit plan delivered, issued  
| for delivery, or renewed on or after January 1, 2020. A health  
| benefit plan delivered, issued for delivery, or renewed before  
| January 1, 2020, is governed by the law as it existed immediately  
| before the effective date of this Act, and that law is continued in  
| effect for that purpose.  
|  SECTION 3. This Act takes effect September 1, 2019.

